Peter Lee

Peter Lee is currently a Partner at AVANT BIO LLC, where he directs early-stage and growth equity investments across the broader healthcare sector. Operating as an experienced capital allocator, he manages portfolios spanning both public and private markets with a specialized emphasis on emerging life science technologies. His core investment mandate specifically targets high-growth enterprises developing advanced tech bio platforms, digital healthtech infrastructure, and novel genetic medicines. Prior to assuming his current partnership role at AVANT BIO, Lee built a comprehensive financial track record evaluating, structuring, and funding complex biotechnology ventures. He actively supports these portfolio companies as they navigate rigorous regulatory environments and complex commercialization pathways within the global healthcare market. Ultimately, his professional background and current strategic focus center on identifying and scaling transformative life science organizations that bridge technological innovation and clinical application.